AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Processa Pharmaceuticals, Inc. Director's Dealing 2024

Sep 18, 2024

35172_dirs_2024-09-18_59c5624e-4a66-4e35-8af0-9d4c0127fdf2.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Processa Pharmaceuticals, Inc. (PCSA)
CIK: 0001533743
Period of Report: 2024-09-03

Reporting Person: Baluch Khoso (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-09-03	Restricted Stock	$0	A	31206	Acquired		Common Stock (31206)	Direct

Footnotes

F1: The restricted stock vest on the earlier of June 28, 2025 or the next annual meeting of stockholders, subject to certain distribution requirements.